Quadratus Lumborum Block for Ventral Hernia
(VHR Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on pain management after surgery, so it's best to discuss your current medications with the trial team.
What data supports the effectiveness of the treatment Quadratus Lumborum Block for Ventral Hernia?
Is the quadratus lumborum block generally safe for humans?
How does the Quadratus Lumborum Block treatment for ventral hernia differ from other treatments?
The Quadratus Lumborum (QL) Block is a unique pain relief method that involves injecting anesthetic near the lower back muscles to numb the abdominal area, which is different from traditional pain management methods that might rely on oral medications or more invasive procedures. This technique is particularly novel for ventral hernia as it provides targeted pain relief with potentially fewer side effects compared to systemic painkillers.1341011
What is the purpose of this trial?
The purpose of this study is to determine whether using a QL block is better than placebo (a look-alike substance that contains no drug) in lowering the amount of opioids you need for pain relief in the first 24 hours and if it improves your recovery following a ventral hernia repair.Participants will be asked to complete a questionnaire before surgery and again at their 30-day follow up. You will also be asked to complete a pain diary 24 hours after surgery and attend a follow-up visit approximately 30 days after surgery.The following information will be collected from you or your medical record:1. Pain medications given to you during surgery.2. Pain medications prescribed to you after surgery, including medication name, dose, units, and frequency.3. Pain levels during the first 24 hours after surgery.4. Your total hospital length of stay after surgery.5. Any complications that you may have experienced after surgery.6. Demographic information, medical history as well as details about your hernia repair surgery.
Research Team
Kaela E Blake, MD
Principal Investigator
The University of Tennessee Graduate School of Medicine
Eligibility Criteria
This trial is for individuals undergoing open ventral hernia repair surgery. Participants should be able to complete questionnaires and a pain diary, and attend follow-up visits. Specific eligibility criteria are not provided, but typically include adults in good health without conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo surgery with either a Quadratus Lumborum block or placebo, and pain management is assessed for 24 hours post-surgery
Hospitalization
Participants are monitored for pain and recovery during their hospital stay, with pain scores recorded daily
Follow-up
Participants complete a questionnaire and attend a follow-up visit approximately 30 days after surgery
Treatment Details
Interventions
- Placebo
- Quadratus Lumborum (QL) Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Tennessee Graduate School of Medicine
Lead Sponsor